%D9%85%D8%AA%D9%84%D8%A7%D8%B2%D9%85%D8%A9_%D9%85%D8%A7%D8%B1%D9%88%D8%AA%D9%88_%D9%84%D8%A7%D9%85%D9%8AS%C3%ADndrome_de_Maroteaux-LamyCategory:Maroteaux%E2%80%93Lamy_syndromeMaroteaux-Lamy-SyndromMaroteaux%E2%80%93Lamy_syndromeMucopolisacaridosis_tipo_VI%D8%A8%DB%8C%D9%85%D8%A7%D8%B1%DB%8C_%D9%85%D8%A7%D8%B1%D9%88%D8%AA%D9%88-%D9%84%D8%A7%D9%85%DB%8CMaroteaux%E2%80%93Lamyn_oireyhtym%C3%A4Maladie_de_Maroteaux-Lamy%D7%AA%D7%A1%D7%9E%D7%95%D7%A0%D7%AA_%D7%9E%D7%A8%D7%98%D7%95-%D7%9C%D7%90%D7%9E%D7%99Sindrome_di_Maroteaux-LamyZesp%C3%B3%C5%82_Maroteaux-Lamy%E2%80%99egoPicnodisostose%D0%A1%D0%B8%D0%BD%D0%B4%D1%80%D0%BE%D0%BC_%D0%9C%D0%B0%D1%80%D0%BE%D1%82%D0%BE_%E2%80%94_%D0%9B%D0%B0%D0%BC%D0%B8%D0%9C%D1%83%D0%BA%D0%BE%D0%BF%D0%BE%D0%BB%D0%B8%D1%81%D0%B0%D1%85%D0%B0%D1%80%D0%B8%D0%B4%D0%BE%D0%B7%D0%B0_%D1%82%D0%B8%D0%BF_VIQ576109
about
sameAs
Diagnosis of Mucopolysaccharidosis Disorders in Patients Presenting With Bilateral Hip DiseaseBiomarker for Maroteaux-Lamy DiseaseStudy of rhASB in Patients With Mucopolysaccharidosis VIEvaluation of Losartan on Cardiovascular Disease in Patients With Mucopolysaccharidoses IV A and VIHuman Placental-Derived Stem Cell TransplantationHematopoietic Stem Cell Transplantation (HCT) for Inborn Errors of MetabolismScreening an Orthopedic Population for Mildly-affected Individuals With Morquio Syndrome A and Maroteaux-Lamy SyndromeEffects of Adalimumab in Mucopolysaccharidosis Types I, II and VILysosomal Storage Disease: Health, Development, and Functional Outcome Surveillance in Preschool ChildrenStudy to Detect Unrecognized Mucopolysaccharidosis in Children Visiting Rheumatology, Hand or Skeletal Dysplasia ClinicsAllogeneic Bone Marrow Transplant for Inherited Metabolic DisordersClinical Trial of Growth Hormone in MPS I, II, and VIA Study in MPS VI to Assess Safety and Efficacy of OdiparcilMT2013-31: Allo HCT for Metabolic Disorders and Severe OsteopetrosisNaglazyme After Allo Transplant for Maroteaux-Lamy SyndromeLongitudinal Studies of Brain Structure and Function in MPS DisordersA Phase 4 Two Dose Level Study of Naglazyme(TM) (Galsulfase) in Infants With MPS VIMucopolysaccharidosis (MPS) VI Clinical Surveillance Program (CSP)Stem Cell Transplantation for HurlerStudy of Recombinant Human N-acetylgalactosamine 4-sulfatase (rhASB) in Patients With MPS VIStudy of Recombinant Human N-Acetylgalactosamine 4-Sulfatase in Patients With MPS VIOpen-Label Study of Efficacy and Safety of Recombinant Human N-acetylgalactosamine 4-sulfatase in Patients With MPS VIStudy of Pulmonary Complications in Pediatric Patients With Storage Disorders Undergoing Allogeneic Hematopoietic Stem Cell TransplantationGene Therapy in Patients With Mucopolysaccharidosis Disease
P1050
P2293
P4044
Q61707503-95DDEF31-62C4-4870-8E57-41FEEEF877BFQ61965859-D93F81EC-EF7F-4E39-B437-FF76CD492A44Q62105892-B8C43808-C4A2-4824-9B64-B885E99D5CFFQ63394716-CD621987-7441-41F3-BADF-E319DF907ED8Q63844511-672063B3-A44D-474E-92F7-6BE3571951FEQ64048189-DF89DDD5-FA23-4754-A881-72A971D5B1B0Q64353069-8153AC7B-9DE9-490B-8923-2649E9D8B27DQ64397300-22F80F19-72BB-4DC3-913A-77E20B07312AQ64612588-DA2A76AB-3CF8-42E4-91B0-2E3067BDF20DQ64642990-C8EFA77C-5873-4D21-8386-01C5903E437AQ64683748-02DB0A6C-CA29-458D-AC8D-30B66C8EA77FQ64716896-DB9EA014-E84C-4800-B3D1-BC71C83E7B1BQ64806543-39DBFD66-897E-479E-85E3-FA8838A84CD3Q65354328-32E6C997-62BE-4311-A3F0-071A8FA5DE00Q65355593-E5429B7E-7316-4A2D-BA08-19EEBD8F434BQ65364187-C2B6768C-6ED8-49F7-B345-BFC5D9CFE4BDQ65537665-12E75274-AAAE-4D0F-B725-DEC07EDDFE75Q65545007-A581604A-7AE2-42FB-BA60-3E364F760F17Q66026514-24AB264D-3814-4D54-8BC8-2491695F5131Q66035072-A4EA97D0-A06A-4278-8247-61610B95C8EAQ66039447-B773F3D1-491D-4AF7-954F-81CC6FD4A986Q66039495-B7145130-79C9-4B9F-A779-C00F3F86E381Q66060113-F5D427F5-16AB-4731-A116-A8D41698C734Q66070001-21CF9087-E51E-4316-A7DD-E2ED545AD4E6
P1050
description
Krankheit
@de
Lysosomal storage disease
@en
forma di mucopolisaccaridosi, ...... lattie da accumulo lisosomiale
@it
genetycznie uwarunkowana choroba metaboliczna, dziedziczona autosomalnie recesywnie
@pl
Лизосомные болезни накопления
@ru
name
Maladie de Maroteaux-Lamy
@fr
Maroteaux-Lamy-Syndrom
@de
Maroteaux–Lamy syndrome
@nl
Maroteaux–Lamyn oireyhtymä
@fi
Mucopolisacaridosis tipo VI
@es
Zespół Maroteaux-Lamy’ego
@pl
mucopolysaccharidosis VI
@en
mukopolysakkaridose VI
@nn
picnodisostose
@pt
sindrome di Maroteaux-Lamy
@it
type
label
Maladie de Maroteaux-Lamy
@fr
Maroteaux-Lamy-Syndrom
@de
Maroteaux–Lamy syndrome
@nl
Maroteaux–Lamyn oireyhtymä
@fi
Mucopolisacaridosis tipo VI
@es
Zespół Maroteaux-Lamy’ego
@pl
mucopolysaccharidosis VI
@en
mukopolysakkaridose VI
@nn
picnodisostose
@pt
sindrome di Maroteaux-Lamy
@it
altLabel
ARSB deficiency
@en
ASB deficiency
@en
MPS VI - Maroteaux-Lamy syndrome
@en
MPS VI
@en
MPS VI
@fi
MPS VI
@nn
MPS6
@en
MPSVI
@en
MUCOPOLYSACCHARIDOSIS TYPE VI; MPS6
@en
Maroteaux - Lamy syndrome
@en
prefLabel
Maladie de Maroteaux-Lamy
@fr
Maroteaux-Lamy-Syndrom
@de
Maroteaux–Lamy syndrome
@nl
Maroteaux–Lamyn oireyhtymä
@fi
Mucopolisacaridosis tipo VI
@es
Zespół Maroteaux-Lamy’ego
@pl
mucopolysaccharidosis VI
@en
mukopolysakkaridose VI
@nn
picnodisostose
@pt
sindrome di Maroteaux-Lamy
@it
P279
P2888
P31
P672
P2581
P486
P6366
P646
P672
P1199
P138
P1417
science/Maroteaux-Lamy-syndrome